Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
Firstenberg MS, Dyke CM, Angiolillo DJ, Ramaiahm C, Price M, Brtko M, Welsby I, Chandna H, Holmes DR, Voeltz M, Tummala P, Hutyra M, Manoukian SV, Prats J, Todd M, Liu T, Chronos N, Dietrich M, Montalescot G, Cannon LA, Topo EJ.
Firstenberg MS, et al.
Heart Surg Forum. 2013 Apr;16(2):E60-9. doi: 10.1532/HSF98.20121103.
Heart Surg Forum. 2013.
PMID: 23625478
Clinical Trial.